Abrdn PLC Hutchmed (China) LTD Transaction History

Abrdn PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 20, 2024	BUY	$7.65 - $15.51 $208,355 - $422,430	27,236 New	27,236 $402,000
Q4 2022 Feb 09, 2023	BUY	$7.65 - $15.51 $89,023 - $180,489	11,637 Added 74.6%	27,236 $402,000
Q3 2022 Nov 10, 2022	BUY	$8.63 - $15.52 $44,159 - $79,415	5,117 Added 48.82%	15,599 $139,000
Q2 2022 Aug 05, 2022	BUY	$8.59 - $20.77 $90,040 - $217,711	10,482 New	10,482 $133,000
Q1 2022 May 04, 2022	SELL	$15.52 - $35.65 $125,463 - $288,194	-8,084 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$28.89 - $35.33 $17,189 - $21,021	595 Added 7.94%	8,084 $284,000
Q3 2021 Nov 15, 2021	BUY	$35.66 - $42.94 $65,971 - $79,439	1,850 Added 32.81%	7,489 $274,000
Q2 2021 Aug 10, 2021	SELL	$23.7 - $39.27 $116,224 - $192,580	-4,904 Reduced 46.51%	5,639 $221,000
Q1 2021 May 06, 2021	SELL	$27.01 - $36.8 $61,501 - $83,793	-2,277 Reduced 17.76%	10,543 $298,000
Q4 2020 Feb 10, 2021	BUY	$27.51 - $34.36 $34,965 - $43,671	1,271 Added 11.01%	12,820 $410,000
Q3 2020 Oct 21, 2020	BUY	$25.8 - $34.61 $297,964 - $399,710	11,549 New	11,549 $373,000
Q3 2019 Nov 13, 2019	SELL	$17.84 - $22.69 $294,360 - $374,385	-16,500 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$22.0 - $31.78 $363,000 - $524,370	16,500 New	16,500 $363,000

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

Stay updated on Abrdn PLC with notifications on news.